Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

April 2, 1997

Inhale granted U.S. patent for pulmonary delivery of osteoporosis drug

March 25, 1997

Aprogenex and Centocor sign licensing agreement

March 24, 1997

Xenova and Zeneca enter drug discovery collaboration

March 21, 1997

Oncogene Science and Sepracor enter drug discovery collaboration

March 20, 1997

Oncogene Science granted rights to Dow's compound library

March 20, 1997

Enzo receives notice of allowance of Japanese patent for antisense technology

March 20, 1997

Lilly and Kyowa Hakko enter combinatorial chemistry collaboration

March 19, 1997

Sparta L.A.D.D. technology covered by U.S. patent

March 19, 1997

In vivo capability of GeneSwitch technology demonstrated

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...